A brand new light-weight, gel-free and waterproof coronary heart monitor that gives real-time insights into coronary heart well being is being trailed at an Australian clinic.
Lubdub’s wearable ECG patch getting used within the scientific trial. Picture Credit score: RMIT College
Initially invented via ground-breaking analysis at RMIT College and now being developed by Aussie start-up Lubdub, the wearable wi-fi patch repeatedly tracks the guts’s rhythm for as much as 14 days – giving medical doctors the identical detailed info as a medical grade electrocardiogram (ECG) Holter monitor.
Sufferers prescribed a Holter monitor will put on the prototype ECG patch as a part of the trial beginning this week at Midlands Medical Specialists in Perth, Western Australia.
Designed to be used past hospitals, the know-how goals to make high-quality coronary heart rhythm monitoring extra accessible by amassing knowledge as sufferers go about their day by day actions.
RMIT Professor and Lubdub co-founder Sharath Sriram stated the ECG patch was the primary of three heart-monitoring applied sciences Lubdub deliberate to convey collectively in a single software program platform, alongside biomarker testing and wearable ultrasound imaging.
The College just lately licensed the mental property for the ECG and biomarker innovations to the corporate.
Earlier testing involving wholesome volunteers discovered the prototype was snug to put on and produced promising outcomes, Sriram stated.
“The versatile sensors make higher contact with the pores and skin than these utilized in conventional Holter screens,” he stated.
Because of this, the information collected by the patch was 18-times cleaner in contrast with the standard Holter screens.
By lowering the work wanted to generate cardiac studies, the know-how might enable the identical workforce to watch as much as 85% extra sufferers earlier than different enabling instruments like AI are applied.”
Sharath Sriram, Professor, RMIT College
The scientific trial will collect proof to assist the know-how’s additional improvement and potential regulatory approval.
Momentum builds
Sriram stated the know-how has attracted robust curiosity from medical consultants due to its potential to cut back delays between signs and remedy and enhance entry to cardiac monitoring in each metropolitan and rural and distant Australia.
“Regardless of the excessive prevalence of heart problems – liable for a 3rd of deaths globally and almost 1 / 4 in Australia – early signs are sometimes missed,” he stated.
“Nearly all of coronary heart failure diagnoses and hospital admissions are unplanned and happen in emergency conditions, with many sufferers reporting signs for years earlier.
“Our innovation is about easier and simpler screening, as a result of prevention is healthier than treatment.”
The Coronary heart Basis selected Lubdub as considered one of its 10 most promising coronary heart well being tasks for 2026.
In September, the corporate introduced an oversubscribed $6 million seed funding spherical, doubling its unique $3 million goal. The spherical was backed primarily by physicians and coronary heart specialists.
Coronary heart well being in a field
Lubdub in the end goals to mix wearable ECG monitoring, non-invasive cardiac biomarker testing and wearable ultrasound imaging right into a single platform.
Accessing the proper diagnostic checks can nonetheless be a prolonged and fragmented course of for individuals with potential coronary heart situations.
Relying on their signs, sufferers might have ECG monitoring, blood checks, or an echocardiogram, typically involving totally different appointments, specialists and amenities.
For Lubdub Co-Founder and Director Nikhilesh Bappoo, the issue is private.
Just a few years in the past, Bappoo’s father suffered a coronary heart assault in Perth and acquired well timed specialist care.
The expertise prompted Bappoo to replicate on the extra restricted entry to specialist healthcare in Mauritius, the place he grew up.
“Had it occurred there, the result might have been very totally different,” he stated.
The expertise strengthened Bappoo’s willpower to make coronary heart testing extra accessible, notably the place value, restricted infrastructure, shortages of specialists and prolonged waits for outcomes can delay prognosis and remedy.
From analysis to commercialization
Lubdub’s ongoing partnership with RMIT consists of analysis grants and contracts, in addition to entry to pilot manufacturing amenities at Discovery to System.
RMIT’s Deputy Vice-Chancellor Analysis and Innovation, Distinguished Professor Calum Drummond AO, stated the licensing settlement with Lubdub confirmed how college analysis might be translated into new merchandise and sensible advantages.
“Lubdub is targeted on making an actual distinction to coronary heart well being via cutting-edge electronics invented proper right here at RMIT,” he stated.
The College will proceed working with Lubdub as the corporate checks and advances the know-how in the direction of regulatory approval.

